Cetirizine Hydrochloride + Phenylephrine Hydrochloride + Paracetamol + CaffeineThird Party Manufacturing in India

Cetirizine Hydrochloride + Phenylephrine Hydrochloride + Paracetamol + Caffeine is a four-component fixed-dose combination designed to address multiple symptoms of the common cold and flu simultaneously. Each active ingredient targets a distinct symptom pathway, resulting in comprehensive relief for the patient.

Cetirizine, a second-generation antihistamine, selectively blocks peripheral histamine H₁ receptors. This prevents histamine from binding to its receptor sites, thereby reducing the allergic response that causes sneezing, runny nose, itchy eyes, and nasal inflammation. Unlike first-generation antihistamines, cetirizine has low lipophilicity and does not readily cross the blood-brain barrier, which significantly reduces sedative effects.

Phenylephrine acts as a selective alpha-1 adrenergic receptor agonist. It constricts blood vessels in the nasal mucosa, reducing blood flow to swollen tissues and decreasing nasal congestion. This vasoconstriction effect opens up the nasal passages, making breathing easier.

Paracetamol works primarily in the central nervous system by inhibiting cyclooxygenase enzymes, particularly COX-2, which reduces prostaglandin synthesis in the brain. This action provides effective antipyretic and analgesic effects, lowering fever and relieving headache, body aches, and sore throat pain.

Caffeine acts as a central nervous system stimulant by antagonising adenosine A₁ and A₂A receptors. This counteracts the drowsiness that some patients may experience from antihistamine therapy and may also enhance the analgesic potency of paracetamol through a synergistic mechanism.

Therapeutic Uses

This combination is prescribed for the symptomatic relief of the common cold and flu, targeting multiple symptoms in a single dose:

• Nasal congestion and sinus pressure: Phenylephrine constricts blood vessels in nasal passages, reducing swelling and congestion for easier breathing.
• Fever and body aches: Paracetamol reduces elevated body temperature and relieves mild to moderate pain including headache, muscle aches, and sore throat.
• Allergic symptoms: Cetirizine controls sneezing, runny nose, watery eyes, and nasal itching associated with colds and seasonal allergies.
• Fatigue and drowsiness: Caffeine helps maintain alertness and counteracts the mild sedative effect of antihistamines, allowing patients to function during illness.

This combination is particularly useful during peak cold and flu seasons when patients need rapid, multi-symptom relief in a single tablet.

Why Manufacturers Choose This Combination

Cetirizine + Phenylephrine + Paracetamol + Caffeine is one of the most widely manufactured fixed-dose combinations in the Indian pharmaceutical market. Its popularity stems from consistent year-round demand driven by seasonal cold and flu cycles. The combination offers manufacturers the advantage of high-volume production with established, well-understood active ingredients that have proven safety profiles over decades of clinical use.

Indian third-party manufacturers produce this combination in large quantities for PCD franchise networks, hospital supply chains, and export to markets across Africa, Southeast Asia, and the Middle East. The tablet formulation is straightforward to manufacture using standard wet granulation or direct compression methods, making it accessible even to mid-scale contract manufacturing facilities.

This makes Cetirizine + Phenylephrine + Paracetamol + Caffeine one of the most sought-after combinations for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies.